Archives: Speakers

Liselotte Wesley Andersen is Chair of Rare Diseases Denmark (Sjældne Diagnoser). At the OCT & CTS Nordics Conference, she represents SBONN – Rare Diseases Nordic Network, bringing a Nordic perspective on patient involvement in rare disease research.

Liselotte holds a PhD in population genetics and worked as a research scientist for more than 30 years before moving into patient advocacy. Today, she works to strengthen the voice of people living with rare diseases in research, healthcare and health policy, with a particular focus on patient empowerment and meaningful involvement in clinical research.

Annemette Broch, Founder & CEO, DATA for GOOD Foundation.

A Professional strategy expert focusing on insights and sharing with more than 30 years experience with predictive modelling, customer orientation and data driven marketing.

Annemette’s history, passion and experience within datadriven marketing, combined with her own ‘health-experience’ has transformed into a mission of securing individuals control of their own data in order to catalyze responsible activation of personal data.

In 2018 she founded DATA for GOOD foundation, and the vision is to create a public good based on a neutral governance infrastructure.

Mateusz Zawadzki is a professional respected for his experience in special cargo supply chain management. In his previous roles, he managed special cargo operations and fostered key account management. Mateusz’s prior experience showcased exemplary proficiency in driving impactful product strategy for specialized product units. The skill set he possesses also to encompass complex air freight problem-solving and risk analysis. Mateusz’s proven track record in customer service and special cargo operations.

Kirsten Bødker is Head of Business Relations and Clinical Facilitator for several disease area networks at Trial Nation, a role she has held since 2020. Trial Nation is a non-profit organisation, primarily publicly funded, working to promote public-private partnership and strengthen the framework conditions for conducting clinical trials in Denmark, in close collaboration with authorities, hospitals, patient organisations, and life science companies.

Prior to joining Trial Nation, Kirsten spent twelve years in Medical Affairs at a multinational pharmaceutical company, much of that time in Nordic-wide positions. Before this, she led a clinical research unit at Copenhagen University Hospital, Hvidovre, for more than a decade.
With over three decades of experience spanning clinical research, medical affairs, and clinical trial facilitation, Kirsten brings deep expertise in bridging academia, healthcare,

Olivia Vu Van is a Clinical Project Manager at Integrative Research Laboratories (IRLAB), a Swedish company, rooted in Nobel Prize-winning research, focusing on CNS disorders, and especially Parkinson’s Disease. She has worked within clinical operations for the past 10 years from hands-on clinical trial leadership in large biopharmaceutical companies to cross-functional coordination in small biotech organizations. For the last years, as the main point of contact for the CROs conducting IRLAB’s trials, Olivia has been responsible for end-to-end trial delivery, ensuring vendor/CRO oversight, regulatory readiness and operational consistency within the organization.

Rasmus Jakobsen is a digital innovation leader with extensive experience at the intersection of clinical development, artificial intelligence, and life sciences. As Senior Manager of Trial Digital Innovation at Genmab, he leads the development and implementation of AI-enabled solutions that support clinical trial operations, including applications for risk-based quality management, knowledge management, and digital transformation.

Throughout his career at Genmab, LEO Pharma, and NNIT, Rasmus has driven the adoption of AI, data analytics, and agile ways of working in highly regulated pharmaceutical environments. He has led cross-functional teams and strategic initiatives spanning clinical operations, R&D, and digital innovation, with a strong focus on translating emerging technologies into compliant, practical solutions that create measurable value.

With a background in Pharmaceutical Design & Engineering from the Technical University of Denmark, Rasmus combines technical expertise with hands-on experience in clinical research, digital transformation, and organizational change. As a speaker, he shares practical insights on AI in clinical development, digital innovation, and how sponsors can successfully navigate the opportunities and challenges of modernizing clinical trials.